Abner
Lv61
2490 积分
2023-03-30 加入
-
Emerging evidence of targeting non-oncogenic drivers for gastric cancer: Claudin18.2 and beyond
3天前
已完结
-
Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial
7天前
已完结
-
Doublet chemotherapy, triplet chemotherapy, or doublet chemotherapy combined with radiotherapy as neoadjuvant treatment for locally advanced oesophageal cancer (JCOG1109 NExT): a randomised, controlled, open-label, phase 3 trial
12天前
已完结
-
Optimizing the dose and schedule of immune checkpoint inhibitors in cancer to allow global access
18天前
已关闭
-
Anti-PD-1: When to Stop Treatment
18天前
已完结
-
Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer
20天前
已完结
-
The efficacy and safety of retroperitoneoscopic renal pedicle ligation of lymphatic disconnection versus open surgery in the treatment of chyluria: A systematic review and meta-analysis
20天前
已完结
-
Detection of SEZ6, a therapeutic target, in medullary thyroid carcinoma
25天前
已关闭
-
Induction therapy with dabrafenib, trametinib, and PD-1 inhibitor and surgical conversion in unresectable stage III non-small cell lung cancers with BRAF V600E mutation: 2 cases
25天前
已完结
-
Toripalimab-Associated Arthritis and Peripheral Neuropathy
26天前
已完结